| 会议亮点 |
|
|
|
|
| 非酒精性脂肪性肝病研究前沿 |
| 施军平 |
| 杭州师范大学附属医院肝病科, 浙江 杭州 310015 |
|
| Frontiers of research on nonalcoholic fatty liver disease |
| SHI Junping |
| Department of Hepatology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China |
| [1] |
RINELLA M E. Nonalcoholic fatty liver disease:a systematic review[J]. JAMA, 2015, 313(22):2263-2273.
|
| [2] |
KARIM M F, AL-MAHTAB M, RAHMAN S, et al. Nonalcoholic fatty liver disease (NAFLD)-a review[J]. Mymensingh Med J, 2015, 24(4):873-880.
|
| [3] |
MCPHERSON S, HARDY T, HENDERSON E, et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies:implications for prognosis and clinical management[J]. J Hepatol, 2015, 62(5):1148-1155.
|
| [4] |
ADAMS L A, SANDERSON S, LINDOR K D, et al. The histological course of nonalcoholic fatty liver disease:a longitudinal study of 103 patients with sequential liver biopsies[J]. J Hepatol, 2005, 42(1):132-138.
|
| [5] |
DATZ C, FELDER T K, NIEDERSEER D, et al. Iron homeostasis in the metabolic syndrome[J]. Eur J Clin Invest, 2013, 43(2):215-224.
|
| [6] |
BESTE L A, LEIPERTZ S L, GREEN P K, et al. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013[J]. Gastroenterology, 2015,149(6):1471-1482.
|
| [7] |
YOPP A C, CHOTI M A. Nonalcoholic steatohepatitis-related hepatocellular carcinoma:a growing epidemic?[J]. Dig Dis, 2015, 33(5):642-647.
|
| [8] |
TORRES D M, HARRISON S A. Nonalcoholic fatty liver disease:fibrosis portends a worse prognosis[J]. Hepatology, 2015,61(5):1462-1464.
|
| [9] |
ANGULO P, HUI J M, MARCHESINI G, et al. The NAFLD fibrosis score:a noninvasive system that identifies liver fibrosis in patients with NAFLD[J]. Hepatology, 2007, 45(4):846-854.
|
| [10] |
FEDCHUK L, NASCIMBENI F, PAIS R, et al. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2014, 40(10):1209-1222.
|
| [11] |
GORDEN D L, MYERS D S, IVANOVA P T, et al. Biomarkers of NAFLD progression:a lipidomics approach to an epidemic[J]. J Lipid Res, 2015, 56(3):722-736.
|
| [12] |
BELL L N, WANG J, MURALIDHARAN S, et al. Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis:a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study[J]. Hepatology, 2012, 56(4):1311-1318.
|
| [13] |
VERBEEK J, LANNOO M, PIRINEN E, et al. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with nonalcoholic steatohepatitis[J]. Gut, 2015, 64(4):673-683.
|
| [14] |
LASSAILLY G, CAIAZZO R, BUOB D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients[J]. Gastroenterology, 2015, 149(2):379-388.
|
| [15] |
GANZ M, SZABO G. Immune and inflammatory pathways in NASH[J]. Hepatol Int, 2013, 7(Suppl 2):S771-S781.
|
| [16] |
MIELE L, MARRONE G, LAURITANO C, et al. Gut-liver axis and microbiota in NAFLD:insight pathophysiology for novel therapeutic target[J]. Curr Pharm Des, 2013, 19(29):5314-5324.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
